Harper Molly
- SEC CIK
- 0001871470
In the past year, 1 open-market sale filing worth $621.9K and no purchases.
Current role at each company
- CPRX Catalyst Pharmaceuticals, Inc.Directoras of Jul 17, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $621.9K
- 1 filing
- Net
- −$621.9K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Harper Molly as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 16, 2025 (view filing) | Dec 12 | 4 days | Harper MollyDirector | SSaleCommon stock, par value $0.001 per share | −26.7K | $23.25 | −$621.9K | −91.9%2.36K after | 3 lots |
| Nov 29, 2024 (view filing) | Nov 27 | 2 days | Harper MollyDirector | SSaleCommon stock, par value $0.001 per share | −17.5K | $22.00 | −$385.0K | −100.0%0 after | |
| Jun 5, 2024 (view filing) | Jun 3 | 2 days | Harper MollyDirector | SSaleCommon Stock, par value $0.001 per share | −5.33K | $16.30 | −$86.9K | −100.0%0 after | |
| Dec 19, 2023 (view filing) | Dec 15 | 4 days | Harper MollyDirector | SSaleCommon stock, par value $0.001 per share | −14.0K | $14.39 | −$201.4K | −100.0%0 after | 2 lots |